It recently was announced that two leaders in cardiovascular disease science, research and education — the American Heart Association (AHA) and the Cardiovascular Research Foundation (CRF) — are joining forces, which will help strengthen and expand educational opportunities in cardiovascular disease and interventional therapi

August 23, 2022 — In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of a COVID-19 vaccine in England, the risk of myocarditis in unvaccinated individuals after COVID-19 infection was at least 11 times higher compared to people who developed

Key Takeaways from the 2019 Heart Rhythm Society Meeting

Hospitals in the U.S. are suffering under a debilitating post-pandemic financial and operational trauma.

August 23, 2022 — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon.

Increasing prevalence of cardiovascular, COPD and respiratory diseases; development of next-generation non-invasive and minimally-invasive systems

Continuous advances in critical patient care have enabled to develop efficient hemodynamic monitoring systems featuring non-invasive technology and expanded parameters such as continuous BP measurements, measurement of cardiac output by pulse contour method, among others.
NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons

Anthony S.

August 19, 2022 —  Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist.

August 19, 2022 —  Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D. became the second in the world to successfully implant the Impella Bridge-to-Recovery (BTR) heart pump for the technology’s U.S. Food and Drug Administration (FDA) early feasibility study (EFS) investigational device exemption (IDE).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now